by nobilistx | Jan 10, 2019 | Uncategorized |
PORTLAND, Ore., January 10, 2019 (Newswire.com) – Nobilis Therapeutics, a biopharmaceutical company focused on the advancement of innovative Central Nervous System therapies based upon the use of noble gas mixtures, today announced that it has entered into a...
by nobilistx | Jan 6, 2019 | Uncategorized |
PRESS RELEASE JAN 7, 2019 01:00 PST PORTLAND, Ore., January 7, 2019 (PRNewswire.com) – Nobilis Therapeutics, a biopharmaceutical company focused on the advancement of innovative CNS therapies, today announced that it has filed an Investigational New...
by nobilistx | Jan 2, 2019 | Uncategorized |
Together with researchers from the Imperial College of London and the Third Medical Military University in China Nobilis Therapeutics has published the results of an in-vivo and in-vitro study of Argon use in diabetic wound model. The positive results of the study...